About Tung-Yu Wu
Form D filings for MET Biotechnology in 2024 list Tung-Yu Wu as chief executive officer and director.
Tung-Yu Wu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Tung-Yu Wu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Tung-Yu Wu works with at each company, as listed on that company's latest Form D.
MET Biotechnology Inc. · Form D, Feb 9, 2024